GlaxoSmithKline (India)

GlaxoSmithKline (India)

GSK plc is a British multinational pharmaceutical and biotechnology company. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm. It is headquartered in London, England. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for GlaxoSmithKline (India), India, covering academic research published from 2001 to 2024. Read More.


Open Access Percentage

59%


Total
Publications

1.5K


Total Open
Publications

859


Total
Citations

57K


Open Access
Percentage

59%


Total
Publications

1.5K


Total Open
Publications

859


Total
Citations

57K

Wikipedia

Website

download

Breakdown

27% 22% 8% 43%

Publisher Open

27%

Both

22%

Other Platform Open

8%

Closed

43%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0102030405060708090Total Publications
200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

36%OA Journal

OA Journal 36%

255

Hybrid 22%

156

No Guarantees 42%

300

Other Platform Open

Domain 71%

311

Other Internet 20%

90

Institution 19%

82

Preprint 3%

12

Public 0%

1

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
310
DOI
Other Internet
88
Europe PMC
Domain
22
Research Square
Preprint
12
University of Cambridge - Apollo
Institution
11
DANS - Data Archiving and Networked Services
Institution
9
Universita Degli Studi Di Milano - Archivio Istituzionale della Ricerca
Institution
5
Yonsei University Medical Library - YUHSpace
Institution
4
University of Michigan - Deep Blue
Institution
4
Le Centre pour la Communication Scientifique Directe - HAL - Diderot
Institution
4
1 / 7

Data updated 18 August 2025

Share

Share

Share